ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Avadel Pharmaceuticals Issues 2018 Corporate Outlook
biospace
January 02, 2018Avadel Pharma?(NASDAQ:AVDL), “Avadel” or “the Company,” today announced its 2018 corporate objectives and financial expectations, including the commercial launch of Noctiva? and the anticipated filing of a New Drug Application (NDA) for both FT218
Pharma Sources Insight January 2025
